IRB Number:

124-01

Trial Status:

Open for Enrollment

Phase: IV

Why is this study being done?

The research study is being done to find out which treatment Tacrolimus or Sirolimus leads to better long-term kidney function. At the time of transplant or about 1 month later patients will be placed in one of two groups, Tacrolimus or Sirolimus

Who is Eligible to Participate in the Study?

All kidney transplant recipients from living and deceased donors between the ages of 18 and 75 may be eligible to participate in this research study.

Minimum Age:

18

Maximum Age:

75

What is Involved With this Study?

You will need to return for your routine post transplant visits at months 4, 12 & 24.

How long will the Study run?

Participants will be enrolled in this research study for up to 24 months.

Who can I Contact for Additional Information on this Trial?

For more information or to participate in this research study please contact Cindy Groettum at (507) 266-8725.

What is/are the Locations of this Clinical Trial?

• Rochester, MN
• Jacksonville, FL
• Scottsdale and Phoenix, AZ

Last updated: 03/29/2006